Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Browsing Category
Drug Prices
CMS Announces Part D Premiums Are Going Down
On July 31, 2017, the Centers for Medicare and Medicaid Services (CMS) announced that Medicare Part D premiums will drop in 2018.…
Ohio “Drug Price Relief Act” Ballot Update
We have previously written about the ballot proposition that is scheduled to be on the ballot in Ohio this November as Issue #2.…
What Does the Nevada Law Mean for Pharma?
We have written several articles on the Nevada bill that requires patient advocacy organizations to report all payments they…
Maryland Law to Restrict Generic Drug Price Increases
Late last week, Maryland Governor Larry Hogan allowed a law targeted at preventing generic drug prices from increasing by too…
Drug Prices Are Growing at Slowest Rate in Years
You’d think, from listening to politicians and news anchors, that the cost of prescription drugs is the highest it has ever been,…
Drug Pricing Legislation Heats Up
Over the last two years, bipartisan Congressional interest in addressing prescription drug prices has been piqued. The interest is…
Mylan Settlement Classified as “Too Low”
Many of our readers may remember back in October 2016, when Mylan agreed to pay $465 million to settle claims related to the way…
New Analysis Shows Out-of-Pocket Spending Based on List Price
New analysis from Amundsen Consulting, a division of QuintilesIMS, shows that more than half of commercially insured patients’…
Drug Shortages, Pricing, and Regulatory Activity
In a paper titled Drug Shortages, Pricing, and Regulatory Activity, Christopher Stromberg of Bates White Economic Consulting…
Maryland Sends Bill to Governor on Drug Prices
The Maryland House recently passed a bill – House Bill 631 – with the goal of “prohibiting a manufacturer or wholesale distributor…